Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Myriad Genetics, Inc. (MYGN) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (1737)	12/19/2005 5:07:38 PM
From: tuck	Read Replies (1) \| Respond to of 2355

Rick or someone, Given that the Flurbie PIII is supposedly enrolling on schedule and is a 12 month study, when are we going to see data from it? Has management mentioned an interim look? If not, they amended the protocol in June, but probably had some enrollment of folks who qualified for the new population, so . . . third quarter of '06 is my guess, but if someone can confirm or correct me, I'd appreciate it. And when are we getting a look at the just INDed cancer compounds? Trying do develop my MYGN trading strategy around these dates, if they are known; thanks for any help. Cheers, Tuck